Clinical Trials Browser

Phase 1/2 × Terminated × FED × Clear all

NCT04037462 2024-06-14

Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy

Phase 1/2 Terminated

2 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung